Leflunomide in dermatology
- PMID: 21962758
- DOI: 10.1016/j.jaad.2011.08.025
Leflunomide in dermatology
Abstract
Leflunomide is an oral disease-modifying antirheumatic drug administered to patients with rheumatoid and psoriatic arthritis. This drug inhibits dihydroorotate dehydrogenase, an enzyme critical in the production of intracellular pyrimidines, and down-regulates tumor necrosis factor-alfa activity. Leflunomide has demonstrated usefulness in treating cutaneous psoriasis along with other dermatologic and rheumatologic conditions.
Copyright © 2011 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
Similar articles
-
[Leflunomide--a new drug for pharmacological immunomodulation].Hautarzt. 2002 May;53(5):309-15. doi: 10.1007/s001050100287. Hautarzt. 2002. PMID: 12063741 Review. German.
-
Leflunomide improves psoriasis in patients with psoriatic arthritis: an in-depth analysis of data from the TOPAS study.Dermatology. 2006;212(3):238-49. doi: 10.1159/000091251. Dermatology. 2006. PMID: 16549920 Clinical Trial.
-
Leflunomide: dermatologic perspective.J Dermatolog Treat. 2013 Apr;24(2):89-95. doi: 10.3109/09546634.2011.595383. Epub 2011 Jul 31. J Dermatolog Treat. 2013. PMID: 21801113 Review.
-
Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.Chin Med J (Engl). 2003 Aug;116(8):1228-34. Chin Med J (Engl). 2003. PMID: 12935395 Clinical Trial.
-
Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases.Expert Rev Clin Pharmacol. 2015 May;8(3):315-20. doi: 10.1586/17512433.2015.1019343. Epub 2015 Feb 24. Expert Rev Clin Pharmacol. 2015. PMID: 25712857 Review.
Cited by
-
Leflunomide Sustained Skin Delivery Based on Sulfobetaine-Modified Chitosan Nanoparticles Embedded in Biodegradable Polyesters Films.Polymers (Basel). 2021 Mar 21;13(6):960. doi: 10.3390/polym13060960. Polymers (Basel). 2021. PMID: 33800966 Free PMC article.
-
Epigenetic Regulation of Ferroptosis-Associated Genes and Its Implication in Cancer Therapy.Front Oncol. 2022 Jan 31;12:771870. doi: 10.3389/fonc.2022.771870. eCollection 2022. Front Oncol. 2022. PMID: 35174081 Free PMC article. Review.
-
Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines Inhibitors of Human Dihydroorotate Dehydrogenase (DHODH).J Med Chem. 2015 Jul 23;58(14):5579-98. doi: 10.1021/acs.jmedchem.5b00606. Epub 2015 Jun 30. J Med Chem. 2015. PMID: 26079043 Free PMC article.
-
Advancements in the Transdermal Drug Delivery Systems Utilizing Microemulsion-based Gels.Curr Pharm Des. 2024;30(35):2753-2764. doi: 10.2174/0113816128305190240718112945. Curr Pharm Des. 2024. PMID: 39092731 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical